Tech policy broadly defined becomes more important each presidential election, and this one is no different. As it has in every cycle since 2008, ITIF provides a side-by-side comparison of the nominees’ positions on key issues related to the progress of technological innovation.
Science and R&D
January 6, 2020
Fact of the Week: Switzerland Increased its Public R&D Investment by 79 Percent Between 2008 and 2016, Nearly 4 Times More Than the United States
The has been a growing disparity across the globe between the governments that are choosing to prioritize innovation and those that aren’t. Recent analysis reflects this, comparing the growth of public R&D funding between 2008 and 2016 across eight major countries.
January 6, 2020
An examination of the scholarly literature shows that China’s mercantilist-powered economic rise and trade expansion have slowed the progress of innovation in the global economy—particularly in North America and Europe.
December 11, 2019
ITIF and the Brookings Metropolitan Policy Program presented a proposal for a national competition to select metropolitan areas to receive a decade-long range of robust policy supports, enabling their transition into self-sustaining, globally competitive innovation hubs.
December 9, 2019
Fact of the Week: A 10 Percent Increase in Public Investment in Defense R&D Increases Private R&D Investment by 4.3 Percent
Defense spending is the main source of public R&D investment in the United States, totaling $78 billion in 2016. A new study examines the impacts of defense R&D investment by leveraging the dramatic increases in defense R&D investment across the OECD in the years following 2001.
December 9, 2019
The federal government should take aggressive steps to spur the development of more tech hubs in America’s heartland by identifying promising metro areas and helping them transform into self-sustaining innovation centers.
November 25, 2019
Fact of the Week: A 40 Percent Reduction in U.S. Drug Prices Would Lead to as Much as 60 Percent Fewer Novel Compounds Reaching Clinical Testing
Proponents of capping drug prices often dismiss concerns about the impact on pharmaceutical R&D by pointing to the fact that drug prices are much lower internationally than in the United States. But this reasoning fails to consider that price restrictions in other countries have made pharmaceutical companies disproportionately reliant on revenue from the United States.
November 4, 2019
Fact of the Week: Large, Profitable Firms in France Receive Tax Subsidies of 43 Percent on R&D They Perform, Which is More Than 8 Times Greater Than U.S. Subsidies
R&D tax incentives are key to fostering innovation, effectively providing needed public support for research without sacrificing private-sector market incentives. According to a new report by the OECD, the United States is well behind much of the rest of the world in this respect.
October 25, 2019
Stephen Ezell presented about globalization trends and what Europe must do to turbocharge its digital economy at an event hosted by the Spanish think tank Cercle d’ Economia on October 25, 2019.
October 23, 2019
Nearly 25 percent of all R&D expenditures in China come in the form of government subsidies to firms. It would be ideal if China dramatically reduced these innovation subsidies so American workers in innovation industries would face a level playing field, but the chances of that happening are slim to none. It is time for the federal government to step up its game and provide significantly more support for industrial R&D.
October 21, 2019
The United States continues to fall further behind world leaders in funding for university research. To reverse course, it should increase support by $45 billion per year and provide stronger incentives for businesses to increase their investments.